Ledger.Open graph →
SEC Form D · Amendment · filed January 30, 2018

Primmune Therapeutics, Inc

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CARLSBAD, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Paulo S. Rangel · Carlsbad, CAExec · DirectorJames R. Appleman · Carlsbad, CAExec · DirectorTodd J. Harris · Carlsbad, CADirectorJanet Huffman · Sarasota, FLDirectorErnest D. Mario · Palo Alto, CAExec · DirectorJonathan Mason · New York, NYExec · DirectorRoger E. Vertrees, Phd · Bertram, TXExec · DirectorLeon A. Wells · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗